CIMIC – Buy Call Options

Posted on | by Leon Hinde

CIM:ASX is likely to see improved earnings in FY22 and we expect to soon see a recovery in the share price.

CIMIC is a high-risk counter trend investment with the prospect of a multi-year recovery, once earnings hit an inflection point.

Buy Dec $20 call options as a stock replacement strategy. For more detail, please call 1300 614 002.

ASX200 BEAR ETF

Posted on | by Leon Hinde | Leave a Comment on ASX200 BEAR ETF

BetaShares Australian Equities Bear Hedge

The inverse ETF’s over the ASX200 are performing well. BEAR (single inverse ETF) and BBOZ (double inverse ETF) are both trading higher as the ASX200 XJO index retreats from the recent highs.

These instruments act as a hedge against existing long equity holdings or as an outright trading position in portfolios.

Chart – BEAR ETF

Apply a stop loss, should the XJO index reverse and trade up through the highlighted range.

Cure ETF – Buy

Posted on | by Leon Hinde

CURE:AXW is under Algo Engine buy conditions and the current pullback provides another buying opportunity.

ETFS S&P Biotech ETF (ASX Code: CURE) offers investors exposure to U.S. biotechnology companies. These companies are engaged in research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering.

.

Cure ETF – Buy

Posted on | by Leon Hinde

CURE:AXW is under Algo Engine buy conditions and the current pullback provides another buying opportunity.

ETFS S&P Biotech ETF (ASX Code: CURE) offers investors exposure to U.S. biotechnology companies. These companies are engaged in research, development, manufacturing and/or marketing of products based on genetic analysis and genetic engineering.

.